EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy

Chao-Jie He, Chun-Yan Zhu, Hong-Yan Fan, Ye-Zhou Qian, Chang-Lin Zhai, Hui-Lin Hu

Clinical Cardiology · 2023-12 · 46 (12) · 1569-1577

DOI: 10.1002/clc.24156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 15.09.2023. Verfasst von Chao-Jie He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China. Hauptthemen laut MEDLINE: Euthyroid Sick Syndromes, Cardiomyopathy, Hypertrophic, Heart Diseases, Heart Failure. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China, Provincial-Municipal Joint Construction of Key Medical Disciplines in Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertrophic cardiomyopathy (HCM) is a common cardiac genetic disorder that clinically manifests with sudden death and progressive heart failure. Moreover, thyroid dysfunction is associated with increased cardiovascular morbidity and mortality risks. Therefore, this study aimed to clarify whether thyroid hormones could serve as an independent predictor of adverse events in patients with HCM.

Methods

The cohort consisted of 782 patients with HCM who had thyroid hormones baseline data and were admitted to the Affiliated Hospital of Jiaxing University. Patients were divided into two groups according to serum levels of free triiodothyronine (fT3): the normal fT3 and low triiodothyronine (T3) syndrome groups. Low T3 syndrome was defined as fT3 < 2.43 pmol/L with a normal thyroid‐stimulating hormone (TSH) level. Patients whose TSH levels were abnormally high or abnormally low were excluded from this study. The primary endpoint was the occurrence of sudden cardiac death (SCD) events, and the secondary endpoint was a composite of worsening heart failure (WHF) events, including heart failure death, cardiac decompensation, hospitalization for heart failure, and HCM‐related stroke. The Kaplan–Meier and Cox regression were performed for the survival analysis.

Results

After a median follow‐up of 52 months, 75 SCD events and 134 WHF events were recorded. The Kaplan–Meier survival curves showed that the cumulative incidence of SCD events and WHF events were significantly higher in patients with low T3 syndrome (log‐rank p = .02 and log‐rank p = .001, respectively). Furthermore, multivariate Cox regression analysis demonstrated that low T3 syndrome is a strong predictor of SCD events and WHF events (adjusted hazard ratio [HR: 1.53, 95% confidence interval [CI]: 1.13–2.24, p < .01; HR: 3.87, 95% CI: 2.91–4.98, p < .001, respectively).

Conclusions

Low T3 syndrome is highly prevalent among patients with HCM and was independently associated with an increased risk of SCD events and WHF events. The routine assessment of serum fT3 levels may provide risk stratification in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Euthyroid Sick SyndromesCardiomyopathy, HypertrophicHeart DiseasesHeart FailureHumansTriiodothyronineRisk FactorsDeath, Sudden, CardiacThyrotropinPrognosis

Stichwörter der Autor:innen

heart failurehypertrophic cardiomyopathylow T3 syndromesudden cardiac death

Substanzen

TriiodothyronineThyrotropin

Autor:innen und Institutionen

  • Department of Cardiology, The Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
  • Department of Anesthesiology, The Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.

Förderung

  • Zhejiang Provincial Natural Science Foundation of China
  • National Natural Science Foundation of China
  • Provincial-Municipal Joint Construction of Key Medical Disciplines in Zhejiang Province
  • Pioneer innovation team of Jiaxing Arteriosclerotic Diseases Research Institute
  • Jiaxing Institute of Arteriosclerotic Diseases
  • Jiaxing Key disciplines
  • Peak Discipline Established by the First Hospital of Jiaxing

Zitieren

APA

He, C. J., Zhu, C. Y., Fan, H. Y., Qian, Y. Z., Zhai, C. L., & Hu, H. L. (2023). Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy. Clinical Cardiology, 46(12), 1569-1577. https://doi.org/10.1002/clc.24156

Vancouver

He CJ, Zhu CY, Fan HY, Qian YZ, Zhai CL, Hu HL. Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy. Clinical Cardiology. 2023;46(12):1569-1577. doi:10.1002/clc.24156

BibTeX
@article{He2023,
  author = {He, Chao-Jie and Zhu, Chun-Yan and Fan, Hong-Yan and Qian, Ye-Zhou and Zhai, Chang-Lin and Hu, Hui-Lin},
  title = {Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy},
  journal = {Clinical Cardiology},
  year = {2023},
  volume = {46},
  number = {12},
  pages = {1569--1577},
  doi = {10.1002/clc.24156}
}
Kostenlos starten →